Compare PDEX & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDEX | FOCL |
|---|---|---|
| Founded | 1978 | N/A |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.4M | 203.7M |
| IPO Year | 1995 | 1998 |
| Metric | PDEX | FOCL |
|---|---|---|
| Price | $62.56 | $4.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $56.00 | N/A |
| AVG Volume (30 Days) | 62.1K | ★ 194.6K |
| Earning Date | 05-01-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 345.00 | N/A |
| EPS | ★ 3.27 | N/A |
| Revenue | $66,593,000.00 | ★ $70,527,000.00 |
| Revenue This Year | $7.22 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.83 | ★ N/A |
| Revenue Growth | ★ 23.68 | 1.63 |
| 52 Week Low | $23.52 | $4.01 |
| 52 Week High | $69.86 | $6.40 |
| Indicator | PDEX | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 35.06 |
| Support Level | $60.40 | $4.01 |
| Resistance Level | $68.86 | $5.64 |
| Average True Range (ATR) | 3.11 | 0.28 |
| MACD | -0.43 | -0.06 |
| Stochastic Oscillator | 38.20 | 15.59 |
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.